TALS - Talaris Therapeutics Inc (Healthcare: Biotechnology) Projected Earnings Date: 0000-02-29    (Delayed quote data   2025-07-11)
Last
 17.98		 Change
 ⇑ +1.70   (+10.44%)		 Volume
  157,332
Open
 17.26		 High
 18.08		 Low
 17.07
8EMA (Daily)
 16.73		 40EMA (Daily)
 16.88		 50EMA (Daily)
 16.81		 STO (Daily)
 32.441		 MACD Hist (Daily)
 -0.027
8EMA (Weekly)
 17.129		 40EMA (Weekly)
 17.63		 50EMA (Weekly)
 17.74		 STO (Weekly)
 68.353		 MACD Hist (Weekly)
 0.550
Company Profile
Talaris Therapeutics Inc is a late-clinical stage biotechnology company. It is developing transformative cell therapies with the potential to eliminate the burden of chronic immunosuppression for organ transplant recipients as well as induce durable remissions in patients with severe autoimmune and immune-mediated disorders.
optionchance optionchance
⇒ Home | Chart and Research | Education | About Us  

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.

Questions or Comments: support@optionchance.com
Copyright © 2025 OptionChance.com